Navigation Links
Health Robotics Announces the Early Release of the i.v.STATION(TM) Profile Option and DUPHAT Presentation
Date:3/25/2009

BOZEN, Italy, March 25 /PRNewswire/ -- Health Robotics today announced the early release in the second half of 2009 of its i.v.STATION Profile option with a presentation [P13] at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT) http://www.duphat.ae/parallelSession.php on March 31, 2009 by Gaspar DeViedma, along with related booth exhibitions.

This i.v.STATION Profile option [at no additional cost] was originally scheduled to be released in 2010, and to be concurrently timed with non-American hospitals that demanded secure [biometric-ID] nurse-station-based access to IV Medications prescribed for a given patient's electronic medical record [patient-specific]. This i.v.STATION Profile option works similarly to Profile options of existing Medication Dispensing Cabinets from multiple vendors [Pyxis, Omnicell, McKesson, Amerisource Bergen, etc.] routinely utilized for dispensing Oral Medications and Not-Ready-to-Administer Vials in nurse stations [wards] around the world.

During the pre-installation meetings recently conducted by i.v.STATION architects' Paolo Giribona and Gaspar DeViedma with the 8 American customers scheduled to install i.v.STATION in Summer/Fall of 2009, it became evident that at least some of our American customers desired to join their non-American counterparts in complementing the use of i.v.STATION's central pharmacy compounding with i.v.STATION's distributed compounding at selected patients' locations that lacked pharmacists' physical presence on a 24/7 basis. Consequently, Health Robotics has decided to release the i.v.STATION Profile option six to twelve months early.

"Our plan is to start an i.v.STATION Profile beta implementation in one of our Adult Intensive Care Units. We expect that having this type of technology near the point-of-care will improve turn-around-time issues and will provide immediate life-critical coverage where our pharmacists cannot be physically present on a 24/7 basis. We expect that the i.v.STATION Profile Robot will deliver IV Medications to our Nursing staff, after they have been safely reviewed and approved remotely by our staff pharmacists, including an audit trail of all i.v.STATION Profile compounding steps and a digital picture review of the medication vials utilized in the compounding process", said Scott Evans, Pharm.D., Chief Operating Officer, USC University Hospital and USC Norris Cancer Hospital.

i.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, cost effective, and ready-to-administer IV Admixtures. Constructed around a scalable, distributed, and fail-safe architecture, i.v.STATION offers unprecedented final container flexibility, life-critical patient safety, and robotic precision and performance. i.v.STATION may be deployed in a variety of locations, including central and satellite pharmacies and direct patient care areas, due to its self-contained form, ISO Class 5 environment, and small "foot print". Pharmacies may, for the first time, choose a robotic configuration that suits their needs, rather than being forced into the dated alternative of "one-size-fits-all, million-dollar-plus" robots. Whether a Pharmacy chooses a single or multiple i.v.STATION configurations, it will benefit from fully automated compounding while producing its ready-to-administer IV doses in a variety of syringe, bag, vial, and tamper-evident caps from diverse medical suppliers such as Baxter, B.Braun, Beckton Dickinson, Hospira, IMF, Covidien, and Terumo. i.v.STATION also supports "just-in-time IV filling" to reduce urgent turn-around-time issues of life-critical patients while avoiding premium prices associated with pre-filled bags and syringes and high cost CST devices, which are made obsolete by the i.v.STATION technology.

"While some competitors are entering the fifth annual delay in five years, halting all installations and manufacturing for at least a year in order to re-design their robots, and withdrawing products and features from their web sites, Health Robotics keeps demonstrating on-time and on-budget deliveries to customers worldwide and proving to the market that the future of safe, sterile, and ready-to-administer IV Medications is already a reality. There is no longer a need to wait to see if decade-long promises will be fulfilled", stated Werner Rainer, Health Robotics' CEO.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, with forty-five-times more units sold that all of its competitors combined, and providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs] and i.v.STATION [non-hazardous IVs] have and will greatly contribute to ease global hospitals' and clinics' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and contamination risks, and to work more efficiently, increase throughput, reduce waste, and contain costs.

    For additional information, please contact:

    Health Robotics,
    Gaspar G. DeViedma,
    Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100,
    USA: +1-609-980-7976,
    EUROPE: +39-346-963-4934,
    gaspar.deviedma@health-robotics.com .



'/>"/>
SOURCE Health Robotics SRL
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... (PRWEB) , ... May 24, ... ... announcement of Essette Dashboard, its highly anticipated, web-based software module. The cutting-edge ... The application’s “secret sauce”? Integration with Izenda’s self-service business intelligence solution and ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... anniversary and has kicked off its 5th Annual Photo Contest. The label contest ... annual event. This year's prizes include a GoPro Hero4, a 40-inch high-definition flat-screen ...
(Date:5/23/2016)... ... May 23, 2016 , ... On Sunday, May 15, ... million, 64-room assisted living center. After 18 months of construction, the new state-of-the-art ... new building provides the latest in assisted living amenities and services, offering six ...
(Date:5/23/2016)... ... 2016 , ... Edward D. Buckingham, M.D . is excited announce that ... roster is put out by the National Consumer Advisory Board to honor excellence in ... considered for this award. , The National Consumer Advisory Board (NCAB) is a private ...
(Date:5/23/2016)... ... , ... According to an article published May 11th on The ... who could benefit from bariatric surgery are actually undergoing the procedure. The article explains ... it offers to obese patients from 6,000 to 50,000 a year, it will not ...
Breaking Medicine News(10 mins):
(Date:5/22/2016)... 23, 2016 DS Biopharma ... and anti-inflammatory compound DS102 in chronic obstructive pulmonary ... steatohepatitis (NASH) patients. Recent DS preclinical ... lung tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic ... The Company will publish further detail on these ...
(Date:5/20/2016)... ReportsnReports.com adds "Plaque Psoriasis ... research report with comprehensive information on the therapeutic ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
(Date:5/19/2016)... Oregon , May 19, 2016 ... titled, World Medical/Diagnostic Imaging Market -Opportunities and Forecasts, 2015 ... reach $45.0 billion by 2022, registering a CAGR of ... expected to continue to be the highest revenue-generating segment ... accounted for around one-third of the market share ...
Breaking Medicine Technology: